Share this article on:

Significant Decrease of Ethinylestradiol With Nevirapine, and of Etonogestrel With Efavirenz in HIV-Positive Women

Landolt, Nadia K. MD, PhD*; Phanuphak, Nittaya MD, PhD†,‡; Ubolyam, Sasiwimol MSc*; Pinyakorn, Suteeraporn MSc*; Kerr, Stephen PhD*,§; Ahluwalia, Jennisa RN*; Thongpaeng, Parawee RN*; Thammajaruk, Narukjaporn MSc*; Cremers, Serge PharmD, PhD; Thomas, Tiffany PhD; Chaithongwongwatthana, Surasith MD; Lange, Joep M. A. MD, PhD*,#; Ananworanich, Jintanat MD, PhD*,†,‡,¶

JAIDS Journal of Acquired Immune Deficiency Syndromes: June 1st, 2014 - Volume 66 - Issue 2 - p e50–e52
doi: 10.1097/QAI.0000000000000134
Letters to the Editor

*The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Bangkok, Thailand

The Thai Red Cross AIDS Research Centre, Bangkok, Thailand

SEARCH, Bangkok, Thailand

§The Kirby Institute, The University of New South Wales, Sydney, Australia

Irving Institute for Clinical and Translation, Research Biomarkers Core Laboratory, Columbia University Medical Center, New York, NY

Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

#Department of Global Health, Academic Medical Center, University of Amsterdam, Amsterdam Institute for Global Health and Development, Amsterdam, the Netherlands

Supported by Ratchadapiseksompotch Endowment Fund, Faculty of Medicine, Chulalongkorn University Grant Number RA53/54 (1); RA 55/53, and The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT). The conducting of laboratory tests at the Irving Institute for Clinical and Translation, Research Biomarkers Core Laboratory was also supported by the National Center for Advancing Translational Sciences, the National Institutes of Health, through Grant Number UL1 TR000040.

The authors have no conflicts of interest to disclose.

© 2014 by Lippincott Williams & Wilkins